India potassium clavulanate market
is expected to grow at a steady rate during the forecast period. The India potassium
clavulanate market is driven by mounting incidence of acute bacterial sinusitis
infection in the country. Moreover, this
drug API can be taken by all age groups which is forecasted to positively
influence the market growth. Ongoing research and developmental activities by
key market players is further expected to boost the growth of India potassium
clavulanate market through FY2026.
The India potassium clavulanate
market is segmented based on composition, route of administration, form, distribution channel,
source, application, end user,
company, and region. Based on application, the market can be segmented into respiratory
tract infections, skin infections, UTI, otitis media, gynaecological
infections, bone and joint infections and others. Among these, respiratory
infections segment is expected to dominate the market in the coming years on
account of high growth in the number of people having respiratory disorders.
Also, the effective use of this drug for the treatment of pneumonia is expected
to drive this segmental growth in the years to come.
The major players operating in the
India potassium clavulanate market are MacLeod’s Pharmaceuticals Ltd.., Hetero
Healthcare Ltd., HLL Lifecare Ltd., Novartis India Ltd. (Sandoz), Modi
Mundipharma Ltd., Ikon Remedies Pvt. Ltd., Glenmark Pharmaceuticals Ltd., Elkos
Healthcare Pvt.
Ltd., Lupin Laboratories Ltd., Zee Laboratories Ltd., and others. Major
companies are developing advanced technologies and launching new products in
order to stay competitive in the market. Other competitive strategies include
mergers & acquisitions, research collaborations and new product
developments to expand their geographic reach and to increase their customer
basis.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the
Study:
- To analyze and estimate the market size of India
potassium clavulanate market from FY2016 to FY2019.
- To estimate and forecast the market size of India
potassium clavulanate market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India potassium
clavulanate market based on composition, route of administration, form,
distribution channel, source, application, end user, company, and regional
distribution.
- To identify dominant region or segment in the India
potassium clavulanate market.
- To identify drivers and challenges for India potassium
clavulanate market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in India
potassium clavulanate market.
- To identify and analyze the profile of leading
players operating in India potassium clavulanate market.
- To identify key sustainable strategies adopted
by market players in India potassium clavulanate market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of India potassium clavulanate market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Potassium clavulanate manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to potassium clavulanate
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report, India potassium
clavulanate market has been segmented into following categories, in
addition to the industry trends which have also been detailed below:
- India Potassium Clavulanate Market, By Composition:
- India Potassium Clavulanate Market, By Route of
Administration:
- India Potassium Clavulanate Market, By Form:
- Tablet
- Capsule
- Syrup
- Injection
- India Potassium Clavulanate Market, By Distribution
Channel:
- India Potassium Clavulanate Market, By Source:
- In-house
- Contract Manufacturing Organizations
- India Potassium Clavulanate Market, By Application:
- Respiratory Tract Infections
- Skin Infections
- UTI
- Otitis media
- Gynaecological infections
- Bone and Joint Infections
- Others
- India Potassium Clavulanate Market, By End User:
- India Potassium Clavulanate Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India potassium clavulanate market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India potassium clavulanate
market is an upcoming report to be released soon. If you wish an early delivery
of this report or want to confirm the date of release, please contact us at [email protected]